Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma
Clinical trial NCT03910439 · TERMINATED
Trial details
- NCT number
- NCT03910439
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2020-11-04
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.